| FSDPX | ICBMX | FSDPX / ICBMX | |
| Total Expense Ratio | 0.70 | 1.31 | 53% |
| Annual Report Gross Expense Ratio | 0.70 | 1.31 | 53% |
| Fund Existence | 39 years | 29 years | - |
| Gain YTD | 5.997 | 14.144 | 42% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 1000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 680M | 121M | 562% |
| Annual Yield % from dividends | 0.93 | 0.66 | 142% |
| Returns for 1 year | -10.17 | 1.89 | -538% |
| Returns for 3 years | -10.31 | 9.24 | -112% |
| Returns for 5 years | 20.83 | 56.04 | 37% |
| Returns for 10 years | 30.83 | 70.47 | 44% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| HFSFX | 17.10 | 0.13 | +0.77% |
| Hartford Schroders Intl Cntrrn Val F | |||
| RTNSX | 14.53 | 0.08 | +0.55% |
| Russell Inv Tax-Managed Intl Eq S | |||
| CMRAX | 10.73 | 0.01 | +0.09% |
| Calamos Merger Arbitrage A | |||
| ITGSX | 82.20 | N/A | N/A |
| VY® T. Rowe Price Growth Equity S | |||
| BRWBX | 27.80 | -0.04 | -0.14% |
| MFS Blended Research Growth Eq B | |||